Biocryst Pharmaceuticals (BCRX) Current Deferred Revenue (2010 - 2026)
Biocryst Pharmaceuticals (BCRX) recorded Current Deferred Revenue of $12.32 million in Q2 2026, up 127.8% from the prior quarter.
Powered by 
Analysis
Biocryst Pharmaceuticals (BCRX) Current Deferred Revenue (2010 - 2026) Analysis & Trends
At the end of FY2022, Biocryst Pharmaceuticals reported Current Deferred Revenue of $1.22 million, down 13.9% from FY2021.
- Annual Current Deferred Revenue has a five-year compound annual growth rate of -32.1% (FY2017 to FY2022).
- Across earlier years, Current Deferred Revenue came in at $1.42 million in FY2021 (+847.3%), $150,000 in FY2020 (-92.9%), $2.12 million in FY2019 (+859.3%) and $221,000 in FY2018 (-97.4%).
- The Q2 2026 figure is the highest quarterly Current Deferred Revenue in data going back to Q4 2010.
- Peak year-over-year performance for Current Deferred Revenue in the last five years was growth of 847.3% in Q4 2021, against a decline of 66.4% in Q3 2023 at the low end.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn |
| 10 | Biocryst Pharmaceuticals | 2.13 Bn | 1.05 Bn | 214.41 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 12.32 Mn |
| Mar 31, 2026 | 5.41 Mn |
| Sep 30, 2023 | 522,000.00 |
| Jun 30, 2023 | 1.78 Mn |
| Mar 31, 2023 | 1.20 Mn |
| Dec 31, 2022 | 1.22 Mn |
| Sep 30, 2022 | 1.55 Mn |
| Jun 30, 2022 | 1.52 Mn |
| Mar 31, 2022 | 1.47 Mn |
| Dec 31, 2021 | 1.42 Mn |
| Sep 30, 2021 | 602,000.00 |
| Jun 30, 2021 | 551,000.00 |
| Mar 31, 2021 | 405,000.00 |
| Dec 31, 2020 | 150,000.00 |
| Sep 30, 2020 | 432,000.00 |
| Mar 31, 2020 | 1.07 Mn |
| Dec 31, 2019 | 2.12 Mn |
| Sep 30, 2019 | 221,000.00 |
| Jun 30, 2019 | 221,000.00 |
| Mar 31, 2019 | 221,000.00 |
API Access
Biocryst Pharmaceuticals Current Deferred Revenue API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=current-deferred-revenue&ticker=BCRX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "current-deferred-revenue", "ticker": "BCRX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=current-deferred-revenue&ticker=BCRX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();